Angiokeratoma: Decision Making Methodology for the Diagnosis of Fabry Disease
Anna Zampetti(Università Cattolica del Sacro Cuore), Daniela Antuzzi(Catholic University of America), Claudio Feliciani(University of Parma), Giorgia Cardinali(San Gallicano Hospital), S. Manco(Università Cattolica del Sacro Cuore), Maria Rita Bongiorno(University of Palermo), Nicaela Aspite(San Gallicano Hospital), Dennis Linder(Ben-Gurion University of the Negev), Rossella Parini(MRC Epidemiology Unit), Daniela Kovacs(San Gallicano Hospital), Maria Gnarra(Università Cattolica del Sacro Cuore), Amelia Morrone(Meyer Children's Hospital), Catherine H. Orteu(Royal Free London NHS Foundation Trust)
Cited by 3
Related Papers
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
|Journal of Investigative Dermatology|2014|954
Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study
|Journal of Investigative Dermatology|2005|644
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Melanins and melanogenesis: methods, standards, protocols
|Pigment Cell & Melanoma Research|2013|484
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384